Comparison Chart BrightPath Biotherapeutics Co., Ltd.

Equities

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-21 am EDT			5-day change	1st Jan Change
60 ^JPY	+1.69%		+3.45%	-31.03%

2023	BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥5.1678 million in funding from Macquarie Group Limited	CI
2023	BrightPath Biotherapeutics Co., Ltd. announced that it expects to receive ¥5.1678 million in funding from Macquarie Group Limited	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	BRIGHTPATH BIOTHERAPEUTICS CO., LTD.	Other Biotechnology & Medical Research	+1.69%	+3.45%	-31.03%	-58.33%	-74.68%	26.74M